PLAINSBORO, N.J., Oct. 24, 2008 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a world leader in regenerative medicine, announced today that it has made Forbes magazine's 2008 list of "200 Best Small Companies."
The Forbes 200 Best Small Companies ranking is limited to companies with sales between $5 million and $750 million and a stock price of $5 as of September 29, 2008. A company's ranking is based on return on equity, sales growth, and profit growth over the past 12 months and over five years. Forbes also compares a company's stock performance with that of its industry peers.
"We're very pleased to have been named to Forbes 200 Best Small Companies," said Stuart Essig, Integra's President and CEO. "Since Integra's inception in 1989, Integra has grown from a company with one product - an artificial skin, used in wound and burn care, called Integra(R) Dermal Regeneration Template - to a company with thousands of medical devices and instruments. Today, our company is a market leader in neurosurgery, we've embarked on a similar course in the hand, foot and ankle sector of the orthopedics market, and we've recently entered the spine market. We are well on our way to becoming a successful multi-divisional medical devices company."
Integra LifeSciences Holdings Corporation, a world leader in regenerative medicine, is dedicated to improving the quality of life for patients through the development, manufacturing, and marketing of cost-effective surgical implants and medical instruments. The company's products are used to treat millions of patients every year, primarily in neurosurgery, extremity reconstruction, orthopedics and general surgery. Integra's headquarters are in Plainsboro, New Jersey, and it has research and manufacturing facilities throughout the world. www.Integra-LS.com.
IART-G